Labeling and Marketing for Cannabis Use

JJ
MB
Overseen ByMeghan B Moran, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins Bloomberg School of Public Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study looks at how cannabis product label and marketing claims affect product perceptions, use expectancies, and use intentions among inexperienced and experienced cannabis users. Participants will answer online survey questions on their perceptions of a cannabis product advertisement.

Who Is on the Research Team?

MM

Meghan Moran, PhD

Principal Investigator

Johns Hopkins University

Are You a Good Fit for This Trial?

Inclusion Criteria

I am 21 years old or older.
Live in a US state (or Washington D.C.) in which recreational cannabis sale is legal and implemented
For inexperienced users: lifetime cannabis use >1 & <= 10
See 1 more

Exclusion Criteria

I am younger than 21 years old.
I do not live in a state where recreational cannabis is legal.
Lifetime cannabis use >=100 times
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Online Experiment

Participants engage in a randomized online experiment to assess the effects of cannabis product labeling and marketing claims

1 day
1 online session

Follow-up

Participants are monitored for their perceptions and intentions immediately after viewing the advertisement

Immediately after viewing ad

What Are the Treatments Tested in This Trial?

Interventions

  • Claim
  • Strain label

How Is the Trial Designed?

12

Treatment groups

Experimental Treatment

Active Control

Group I: Sativa/SedatingExperimental Treatment2 Interventions
Group II: Sativa/No claimExperimental Treatment1 Intervention
Group III: Sativa/EnergizingExperimental Treatment2 Interventions
Group IV: No strain/SedatingExperimental Treatment1 Intervention
Group V: No strain/EnergizingExperimental Treatment1 Intervention
Group VI: Indica/SedatingExperimental Treatment2 Interventions
Group VII: Indica/No claimExperimental Treatment1 Intervention
Group VIII: Indica/EnergizingExperimental Treatment2 Interventions
Group IX: Hybrid/SedatingExperimental Treatment2 Interventions
Group X: Hybrid/No claimExperimental Treatment1 Intervention
Group XI: Hybrid/EnergizingExperimental Treatment2 Interventions
Group XII: No strain/No claimActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins Bloomberg School of Public Health

Lead Sponsor

Trials
441
Recruited
2,157,000+